C

Codexis
D

CDXS

4.17000
USD
-0.08
(-1.88%)
Market Closed
Volume
44,427
EPS
-1
Div Yield
-
P/E
-5
Market Cap
339,345,655
Related Instruments
    CI
    CI
    0.07
    (0.02%)
    299.89 USD
    D
    DRI
    -3.870
    (-1.98%)
    191.210 USD
    ECL
    ECL
    -2.67
    (-1.00%)
    264.80 USD
    FDX
    FDX
    -14.350
    (-5.34%)
    254.190 USD
    KR
    KR
    0.690
    (1.07%)
    65.080 USD
    LEN
    LEN
    -2.100
    (-1.71%)
    120.590 USD
    MCD
    MCD
    1.70
    (0.56%)
    304.74 USD
    ORCL
    ORCL
    -8.190
    (-4.65%)
    167.810 USD
    TJX
    TJX
    -1.850
    (-1.50%)
    121.140 USD
    TRV
    TRV
    -1.190
    (-0.49%)
    240.060 USD
    More
News

Title: Codexis

Sector: Healthcare
Industry: Biotechnology
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop and enhance novel, high-performance enzymes. Codexisenzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.